Nicotinamide Mononucleotide (NMN): Difference between revisions

Nicotinamide Mononucleotide (NMN) (view source)

406 bytes added , 2 December 2023

2,851

edits

@@ Line 289: / Line 289: @@
 |-
 |{{pmid text|35927255}}
+|[[RCT]], 12 weeks
+* placebo (n=10)
+* 250 mg (n=10)
 |
+* 20 healthy male
+* Age >= 65
+* BMI 22–28
+* nonsmokers
 |
-|
+* 250 mg of NMN per day for 12 weeks more than doubles blood NAD+ levels in healthy males older than 65.
+* The supplementation regimen improves walking speed and grip strength in the aged men.
+* These findings suggest NMN supplementation may be used to ameliorate age-related muscle deterioration.
 |-
 |{{pmid text|35821806}}